Microbot Medical Inc. MBOT

MBOT Company Overview

Microbot Medical Inc. is a medical technology company focused on the development of robotic-assisted endovascular technologies intended to improve minimally invasive surgical procedures. The company operates within the broader medical device and surgical robotics industries, with a primary emphasis on robotically controlled catheter-based interventions used in vascular and interventional procedures. Its core development platform is the LIBERTY Endovascular Robotic System, which is designed to enable remote manipulation of endovascular devices while reducing radiation exposure and physical strain for physicians.

The company’s primary strategic focus is advancing robotic technologies that support precision navigation in neurovascular, cardiovascular, and peripheral vascular interventions. Microbot Medical has positioned itself as a smaller specialized entrant within the surgical robotics market by concentrating on compact, disposable, and remotely operated robotic systems rather than large-scale operating room robotics platforms. The company traces its origins to Israeli medical robotics research and became publicly traded in the United States through a corporate restructuring and merger process involving prior medical technology assets. Public disclosures and regulatory filings consistently identify robotic endovascular intervention as the company’s principal business activity.